Atossa Therapeutics
ATOS
#10613
Rank
A$29.29 M
Marketcap
A$2.94
Share price
-5.48%
Change (1 day)
129.26%
Change (1 year)

Atossa Therapeutics (ATOS) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$10.57 Million

According to Atossa Therapeutics's latest financial reports the company's total liabilities are A$10.57 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Atossa Therapeutics - Total liabilities on balance sheet (from 2010 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$12.32 M54.34%
2024-12-31A$7.98 M3.91%
2023-12-31A$7.68 M-6.07%
2022-12-31A$8.18 M89.76%
2021-12-31A$4.31 M-78.84%
2020-12-31A$20.38 M969.76%
2019-12-31A$1.9 M-53.97%
2018-12-31A$4.13 M163.66%
2017-12-31A$1.56 M8.04%
2016-12-31A$1.45 M-57.69%
2015-12-31A$3.43 M24.03%
2014-12-31A$2.76 M75.47%
2013-12-31A$1.57 M-0.66%
2012-12-31A$1.58 M7.7%
2011-12-31A$1.47 M72.81%
2010-12-31A$0.85 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$169.84 B 1,605,210.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$12.66 B 119,626.43%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$14.67 B 138,583.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
A$0.73 B 6,843.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A$28.54 M 169.79%๐Ÿ‡บ๐Ÿ‡ธ USA